Literature DB >> 33911015

Association of reperfusion success and emboli in new territories with long term mortality after mechanical thrombectomy.

Morin Beyeler1, Loris Weber1, Christoph C Kurmann2, Eike Immo I Piechowiak2, Pascal J Mosimann2,3, Felix Zibold2, Thomas Raphael Meinel1, Mattia Branca4, Martina Goeldlin1, Sara M Pilgram-Pastor2, Lorenz Grunder5, Marcel Arnold1, David Seiffge1, Raphael Meier2,6, Mirjam R Heldner1, Tomas Dobrocky2, Pasquale Mordasini2, Jan Gralla2, Urs Fischer1, Johannes Kaesmacher7,5.   

Abstract

BACKGROUND: The degree of reperfusion is the most important modifiable predictor of 3 month functional outcome and mortality in ischemic stroke patients treated with mechanical thrombectomy. Whether the beneficial effect of reperfusion also leads to a reduction in long term mortality is unknown.
METHODS: Patients undergoing mechanical thrombectomy between January 2010 and December 2018 were included. The post-thrombectomy degree of reperfusion and emboli in new territories were core laboratory adjudicated. Reperfusion was evaluated according to the expanded Thrombolysis in Cerebral Infarction (eTICI) scale. Vital status was obtained from the Swiss population register. Adjusted hazard ratios (aHRs) using time split Cox regression models were calculated. Subgroup analyses were performed in patients with borderline indications.
RESULTS: Our study included 1264 patients (median follow-up per patient 2.5 years). Patients with successful reperfusion had longer survival times, attributable to a lower hazard of death within 0-90 days and for >90 days to 2 years (aHR 0.34, 95% CI 0.26 to 0.46; aHR 0.37, 95% CI 0.22 to 0.62). This association was homogeneous across all predefined subgroups (p for interaction >0.05). Among patients with successful reperfusion, a significant difference in the hazard of death was observed between eTICI2b50 and eTICI3 (aHR 0.51, 95% CI 0.33 to 0.79). Emboli in new territories were present in 5% of patients, and were associated with increased mortality (aHR 2.3, 95% CI 1.11 to 4.86).
CONCLUSION: Successful, and ideally complete, reperfusion without emboli in new territories is associated with a reduction in long term mortality in patients treated with mechanical thrombectomy, and this was evident across several subgroups. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  stroke; thrombectomy

Mesh:

Year:  2021        PMID: 33911015     DOI: 10.1136/neurintsurg-2021-017422

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  4 in total

Review 1.  The Assessment of Endovascular Therapies in Ischemic Stroke: Management, Problems and Future Approaches.

Authors:  Tadeusz J Popiela; Wirginia Krzyściak; Fabio Pilato; Anna Ligęzka; Beata Bystrowska; Karolina Bukowska-Strakova; Paweł Brzegowy; Karthik Muthusamy; Tamas Kozicz
Journal:  J Clin Med       Date:  2022-03-28       Impact factor: 4.241

2.  Five-Year Outcomes After Endovascular Treatment for Large Vessel Occlusion Stroke.

Authors:  Changxiong Gong; Jiacheng Huang; Weilin Kong; Fengli Li; Chang Liu; Jie Yang; Shuai Liu; Zhongming Qiu; Min Lin; Zhangbao Guo; Zhizhong Yan; Xianjun Huang; Shuai Zhang; Wentong Ling; Peiyang Zhou; Zhen Wang; Yong Liu; Dongzhang Xue; Yaoyi Zhong; Shu Yang; Yue Wan; Jiayang Fang; Wenguo Huang; Huihui Liu; Jun Luo; Rongzhong Li; Changming Wen; Xinmin Fu; Mingyi Tu; Li Wang; Xiguang Tian; Huiyuan Peng; Zhilin Wu; Guoyong Zeng; Wenjie Zi; Qingwu Yang
Journal:  Front Neurosci       Date:  2022-07-13       Impact factor: 5.152

3.  Change of mortality of patients with acute ischemic stroke before and after 2015.

Authors:  Sang-Won Park; Ji Young Lee; Nam Hun Heo; James Jisu Han; Eun Chae Lee; Dong-Yong Hong; Dong-Hun Lee; Byung Cheol Lee; Young Wha Lim; Gui Ok Kim; Man Ryul Lee; Jae Sang Oh
Journal:  Front Neurol       Date:  2022-08-24       Impact factor: 4.086

4.  Heterogeneity of the Relative Benefits of TICI 2c/3 over TICI 2b50/2b67 : Are there Patients who are less Likely to Benefit?

Authors:  Christoph C Kurmann; Adnan Mujanovic; Eike I Piechowiak; Tomas Dobrocky; Felix Zibold; Morin Beyeler; Jan Vynckier; David Seiffge; Thomas R Meinel; Pasquale Mordasini; Marcel Arnold; Urs Fischer; Jan Gralla; Johannes Kaesmacher
Journal:  Clin Neuroradiol       Date:  2022-01-06       Impact factor: 3.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.